Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2021-04-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the first meeting of the third Supervisory Board of Zhejiang Tailin Biotechnology Co., Ltd. It includes approvals of various reports such as the 2020 Annual Report, 2021 Q1 Report, 2020 Supervisory Board Work Report, 2020 Profit Distribution Proposal, 2020 Financial Settlement Report, 2020 Audit Report, and others. However, the document itself does not contain the full reports or detailed financial data but rather states that the full reports are published on the designated disclosure website (cninfo.com.cn). The document is relatively short (4244 characters) and serves as a formal announcement of the meeting resolutions and approvals, not the reports themselves. According to the "Menu vs Meal" rule, this is an announcement of approvals and resolutions related to reports, not the reports themselves. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories and is not the full report itself.
2021-04-25 Chinese
召开2020年度网上业绩说明会的提示性公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of an upcoming online annual performance explanation meeting (业绩说明会) for the year 2020. It invites investors to participate and submit questions in advance. The document does not contain any financial data or results itself, nor does it present a full report. It is essentially a notice about an investor presentation event focused on discussing annual performance. Given the nature of the content, it fits best under the category of Investor Presentation (IP), which covers detailed presentations for investors focusing on financials, strategy, and market position. The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is IP with high confidence.
2021-04-25 Chinese
关于召开2020年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of Zhejiang Tailin Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures (both in-person and online), agenda items to be discussed and voted on (including the 2020 annual report, board reports, profit distribution, financial statements, auditor appointment, remuneration plans, and use of raised funds), registration details, and attachments such as proxy forms and attendance lists. The document does not contain the actual annual report or financial statements but rather serves as a formal notification to shareholders about the AGM and the matters to be voted on. The length is under 5,000 characters, and it is clearly a meeting notice rather than the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2021-04-25 Chinese
2020年度内部控制自我评价及相关意见公告
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-evaluation report for the year 2020 by Zhejiang Tailin Biotechnology Co., Ltd. It discusses the company's internal control system, evaluation methods, scope, governance structure, financial reporting controls, and defect identification and rectification. It includes detailed descriptions of internal control processes, defect standards, and opinions from the board, supervisory committee, independent directors, and the sponsoring institution. The document is comprehensive and contains substantive information about internal control evaluation rather than just an announcement or summary. It is not a full annual report (10-K), but a standalone internal control audit and evaluation report. This fits the definition of an Audit Report / Information (AR) filing, which includes internal control evaluation reports and audit-related disclosures separate from the full annual report. The document length (11,431 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2020
2021-04-25 Chinese
关于聘任高级管理人员、证券事务代表及内审部负责人的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the appointment of senior management personnel, securities affairs representatives, and the head of the internal audit department. It details the names, qualifications, and backgrounds of the appointed individuals, as well as compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in senior management and board-related appointments. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4128 characters, which is sufficient for a detailed announcement but not a full report.
2021-04-25 Chinese
关于控股股东及其关联人占用公司资金情况的专项公告
Regulatory Filings Classification · 95% confidence The document is a special announcement by the board of Zhejiang Tailin Biotechnology Co., Ltd. regarding the situation of funds occupied by the controlling shareholder and its related parties. It references an audit report issued by Tianjian Accounting Firm on the company's 2020 financial statements and a special audit explanation on non-operating fund occupation and related party transactions. The document includes independent opinions from the company's independent directors confirming no fund occupation by controlling shareholders. The document is relatively short (1135 characters) and primarily serves as a disclosure announcement about the audit and independent opinions rather than the audit report itself. It also directs readers to the full audit explanation and independent opinions published on the official disclosure website. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about audit findings and related party transactions, not the full audit report or annual report itself.
2021-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.